Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Large B-Cell, Diffuse × Alemtuzumab × 90 days × Clear all

Sponsor

Conditions

Wilms Tumor 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Pseudomyxoma Peritonei 1 Neuroblastoma 1 Neoplasms, Germ Cell and Embryonal 1 Melanoma 1 Lymphoma 1 Digestive System Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Hepatocellular 1 Adenocarcinoma, Clear Cell 1

Interventions

Cyclophosphamide 38 Rituximab 35 Prednisone 22 Doxorubicin 21 fludarabine 15 Vincristine 15 Specimen Handling 14 Oxaliplatin 14 Magnetic Resonance Spectroscopy 14 Lenalidomide 14 Gemcitabine 14 polatuzumab vedotin 13 CT-P10 11 Etoposide 10 Biopsy 9 fludarabine phosphate 7 deltacortene 7 axicabtagene ciloleucel 7 Leukapheresis 7 Immunotherapy, Adoptive 7 venetoclax 6 prednylidene 6 glofitamab 6 pembrolizumab 5 obinutuzumab 5 ibrutinib 5 acalabrutinib 5 Prednisolone 5 tisagenlecleucel 4 pegfilgrastim 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡